A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
Status:
RECRUITING
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn more about the safety, effectiveness and tolerability of the study drug called Benfotiamine which may delay or slow the progression of the symptoms of early Alzheimer's disease.
Phase:
PHASE2
Details
Lead Sponsor:
Alzheimer's Disease Cooperative Study (ADCS)
Collaborators:
Burke Medical Research Institute National Institute on Aging (NIA)